During the past decade, Fremantle Dermatology conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 16 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 14 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fremantle Dermatology" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "ASLAN Pharmaceuticals" with 2 trials sponsored, "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Dermira, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fremantle Dermatology" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Celtaxsys Aus Pty Limited" with 1 trials as a collaborator and "Clinical Network Services (CNS) Pty Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Fremantle Dermatology" are "Atopic Dermatitis" (10 trials), "Psoriasis" (7 trials), "Acne Vulgaris" (4 trials), "Basal Cell Carcinoma" (3 trials) and "Alopecia Areata" (2 trials). Many other conditions were trialed in "Fremantle Dermatology" in a lesser frequency.

Most popular intervention types in "Fremantle Dermatology" are "Drug" (25 trials), "Biological" (4 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Baricitinib" (4 trials), "Lebrikizumab" (3 trials), "ASLAN004" (2 trials) and "Apremilast" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fremantle Dermatology" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Fremantle Dermatology". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Fremantle Dermatology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fremantle Dermatology, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".